In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

DexCom, Inc.. Trade Record

NASDAQ:DXCM DexCom, Inc. stock gains 20.97% Exit Jun 7, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart DXCM May 2, 2018, priceSeries
About DexCom, Inc.

DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patient's mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud-based reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management. The company also offers sensor augmented insulin pumps. It has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. The company was founded in 1999 and is headquartered in San Diego, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
95.63
Entry Date
May 2, 2018
Entry Price
74.31
Sell Date
Jun 7, 2018
Sell Price
89.89
Net Gain
20.97%
Hold Time
25 Trading Days